The molecular signaling pathway EGFR-STAT1 is key for driving fibrosis (scarring) in scleroderma, according to a new study. The…
Articles by Marisa Wexler, MS
Sexual dysfunction is common among people with systemic scleroderma, but is rarely discussed between patients and their doctors, a…
Infection with Epstein-Barr virus (EBV), the virus that causes mononucleosis, may increase the risk of developing systemic sclerosis (SSc), according…
Efzofitimod was found to be generally safe and well tolerated by patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)…
June is Scleroderma Awareness Month, and the scleroderma community is kicking into gear to spread awareness about the rare,…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to the cell therapy ALLO-329 to treat active…
Some types of disease-specific antibodies are more common in Black patients with scleroderma than white patients, a study shows.
Treatment with Letairis (ambrisentan) — approved to treat pulmonary…
Levels of two blood proteins, calcitonin and SOST, may be markers of lung disease in people with scleroderma, a new…
Living with scleroderma requires adapting to changes in a woman’s sense of self, but practicing gratitude and accepting change…